Reaffirms FY2024 EPS >$34.29; CMS Star update adds ~$190M benefit

Elevance Health, Inc.

Net income guidance >$34.29/sh, includes ~$2.81/sh unfavorable items; adjusted >$37.10/sh.
Four Medicare Advantage contracts received higher 2024 Star Ratings from CMS.
~49% of MA members now in plans rated 4-Star+ based on Jan 2024 enrollment.
Estimated $190M financial benefit from reconsideration for payment year 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.